Pfizer (PFE) +0.3% premarket following new top-line data which shows its Prevenar 13 conjugate...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) +0.3% premarket following new top-line data which shows its Prevenar 13 conjugate vaccine in adults 18-49 years of age met the primary objective for all 13 stereotypes. PFE says the data support its recent EU regulatory filing and plans to support further regulatory submissions applying to the age group.